| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3295695 | Gastroenterology | 2011 | 15 Pages |
Abstract
BCL9-2 promotes early phases of intestinal tumor progression in humans and in transgenic mice. BCL9-2 increases the expression of a subset of canonical Wnt target genes but also regulates genes that are required for early stages of tumor progression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Felix H. Brembeck, Maria Wiese, Nathalie Zatula, Tamara Grigoryan, Yiyang Dai, Johannes Fritzmann, Walter Birchmeier,